摘要
目的:构建LIM激酶(Limk)1不同突变体的HA融合表达载体,并在真核细胞中表达,观察这些突变体在细胞内定位。方法:利用聚合酶链式反应(PCR)扩增Limk1全长序列,构建HA-Limk1真核表达质粒;利用定点突变策略对HA-Limk1进行核定位信号(NLS)缺失突变,命名为Limk1-NLS(del);用合成两条互补序列退火获得目标片段插入载体的策略构建Limk1-NLS;将2表达质粒转染HepG2细胞,细胞免疫荧光方法以及核质分离后用western-blot检测其在细胞中定位。结果:经测序鉴定Limk1及其不同突变体序列正确,在HepG2细胞中高表达;其中HA-Limk1在细胞质、细胞核均有表达,Limk1-NLS(del)主要定位于细胞质,Limk1-NLS主要定位于细胞核。结论:成功构建了Limk1全长及不同突变体的HA融合表达载体,初步明确突变体在细胞内的定位。
Objective: To construct eukaryotic cell expression vectors of different Limkl mutants fused with HA and to study the intracellular localizations of the mutant. Methods: Using polymerase chain reaction (PCR) for amplification of Limkl full sequence, constructing HA-Limkl Eukaryotic Expression Vector; using fixed-mutation to perform NLS deletion mutation, and named it as Limkl- NLS (del) ; using annealed complementary sequence to gain biotinylated target, to insert it in measure- ment building of Limkl-NLS; Mutants of Limkl gene transfected into HepG2 cells,. The intracellular localizations of these mutants were detected with immunofluorescence and western-blot followed to cyto- plasm-nucleoplasm separation. Results: HA-fused Limkl mutants highly expressed in HepG2 ceils. HA-Limkl expressed in both cytoplasm and nucleus. The Limkl-NLS (del) mainly localized in cyto- plasm. The Limkl-NLS mainly localized in nucleus. Conclusions: Limkl full length and different HA fusion expression vectors are successfully constructed, preliminarily define localization of mutants in nucleus.
出处
《贵阳医学院学报》
CAS
2014年第4期475-478,共4页
Journal of Guiyang Medical College
基金
国家自然科学基金(81372692
81302229)
教育部高等学校博士学科点专项科研基金(20134433120014)
广东省自然科学基金(S2012040007081)